Propanc Biopharma (PPCB) Net Income by Year
Propanc Biopharma, Inc. reported a net loss of $18.9M in fiscal year 2026. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 15 fiscal years, from 2012 to 2026, and the quarters Propanc Biopharma, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
PPCB Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
PPCB Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Propanc Biopharma, Inc. financials
Frequently Asked Questions
What was Propanc Biopharma, Inc.'s net income in fiscal year 2026?
Propanc Biopharma, Inc. reported a net loss of $18.9M in fiscal year 2026.
How fast is Propanc Biopharma, Inc.'s net income growing?
Propanc Biopharma, Inc. (PPCB) reported a $58.9M net loss in fiscal year 2025 and a $18.9M net loss in fiscal year 2026. A growth rate is not meaningful here, because the earlier figure was zero or negative.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Propanc Biopharma, Inc. (PPCB) reported on that line in every period on record.